Viewing Study NCT01886859


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-06-06 @ 7:59 PM
Study NCT ID: NCT01886859
Status: COMPLETED
Last Update Posted: 2022-09-26
First Post: 2013-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module